216 related articles for article (PubMed ID: 28144662)
1. Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy.
Le DH; Lee KL; Shukla S; Commandeur U; Steinmetz NF
Nanoscale; 2017 Feb; 9(6):2348-2357. PubMed ID: 28144662
[TBL] [Abstract][Full Text] [Related]
2. Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.
Lee KL; Murray AA; Le DHT; Sheen MR; Shukla S; Commandeur U; Fiering S; Steinmetz NF
Nano Lett; 2017 Jul; 17(7):4019-4028. PubMed ID: 28650644
[TBL] [Abstract][Full Text] [Related]
3. Presentation and Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand via Elongated Plant Viral Nanoparticle Enhances Antitumor Efficacy.
Le DHT; Commandeur U; Steinmetz NF
ACS Nano; 2019 Feb; 13(2):2501-2510. PubMed ID: 30668110
[TBL] [Abstract][Full Text] [Related]
4. Viral nanoparticles for in vivo tumor imaging.
Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of Filamentous Plant Virus Nanoparticles: Pepino Mosaic Virus versus Potato Virus X.
Le DHT; Méndez-López E; Wang C; Commandeur U; Aranda MA; Steinmetz NF
Biomacromolecules; 2019 Jan; 20(1):469-477. PubMed ID: 30516960
[TBL] [Abstract][Full Text] [Related]
6. Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X.
Shukla S; Ablack AL; Wen AM; Lee KL; Lewis JD; Steinmetz NF
Mol Pharm; 2013 Jan; 10(1):33-42. PubMed ID: 22731633
[TBL] [Abstract][Full Text] [Related]
7. Potato Virus X Inactivation and Characterization.
Ma Y; Steinmetz NF
Methods Mol Biol; 2023; 2671():257-271. PubMed ID: 37308650
[TBL] [Abstract][Full Text] [Related]
8. A new application of plant virus nanoparticles as drug delivery in breast cancer.
Esfandiari N; Arzanani MK; Soleimani M; Kohi-Habibi M; Svendsen WE
Tumour Biol; 2016 Jan; 37(1):1229-36. PubMed ID: 26286831
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-tumor efficacy and reduced cardiotoxicity of doxorubicin delivered in a novel plant virus nanoparticle.
Alemzadeh E; Dehshahri A; Dehghanian AR; Afsharifar A; Behjatnia AA; Izadpanah K; Ahmadi F
Colloids Surf B Biointerfaces; 2019 Feb; 174():80-86. PubMed ID: 30445253
[TBL] [Abstract][Full Text] [Related]
10. Chemical addressability of potato virus X for its applications in bio/nanotechnology.
Le DHT; Hu H; Commandeur U; Steinmetz NF
J Struct Biol; 2017 Dec; 200(3):360-368. PubMed ID: 28647539
[TBL] [Abstract][Full Text] [Related]
11. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
[TBL] [Abstract][Full Text] [Related]
12. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
14. Affinity of plant viral nanoparticle potato virus X (PVX) towards malignant B cells enables cancer drug delivery.
Shukla S; Roe AJ; Liu R; Veliz FA; Commandeur U; Wald DN; Steinmetz NF
Biomater Sci; 2020 Jul; 8(14):3935-3943. PubMed ID: 32662788
[TBL] [Abstract][Full Text] [Related]
15. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
16. Milk derived colloid as a novel drug delivery carrier for breast cancer.
Hayashi M; Silanikove N; Chang X; Ravi R; Pham V; Baia G; Paz K; Brait M; Koch WM; Sidransky D
Cancer Biol Ther; 2015; 16(8):1184-93. PubMed ID: 26046946
[TBL] [Abstract][Full Text] [Related]
17. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
18. Small, Smaller, Nano: New Applications for Potato Virus X in Nanotechnology.
Röder J; Dickmeis C; Commandeur U
Front Plant Sci; 2019; 10():158. PubMed ID: 30838013
[TBL] [Abstract][Full Text] [Related]
19. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
20. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
Ling L; Ismail M; Du Y; Yao C; Li X
Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
